News

IND-SWIFT LABORATORIES LTD. announced the appointment of Mr. Amit Mathur as an Additional Director, in the category of Non-Executive Independent Director, effective September 3, 2026, for a period of five years subject to member approval at the company’s 31st Annual General Meeting, scheduled for September 30, 2026. The company also announced the reconstitution of its Audit Committee, effective September 3, 2026, and appointed Care Ratings Limited as the Monitoring Agency for the utilization of proceeds from a preferential issue approved on August 5, 2026.

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 10 August 2026.

Ind-Swift Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 5 August 2026.

Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 10 July 2026.

Net profit of Ind-Swift Laboratories declined 93.20% to Rs 15.11 crore in the quarter ended March 2026 as against Rs 222.27 crore during the previous quarter ended March 2025. Sales rose 22.82% to Rs 169.79 crore in the quarter ended March 2026 as against Rs 138.24 crore during the previous quarter ended March 2025.For the full year,net profit declined 83.46% to Rs 41.42 crore in the year ended March 2026 as against Rs 250.48 crore during the previous year ended March 2025. Sales rose 14.17% to Rs 641.29 crore in the year ended March 2026 as against Rs 561.71 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales169.79138.24 23 641.29561.71 14 OPM %12.11-6.66 -7.03-3.45 - PBDT25.2222.02 15 90.6659.08 53 PBT17.1114.58 17 60.0634.60 74 NP15.11222.27 -93 41.42250.48 -83 Powered by Capital Market - Live News